Cardiometabolic criteria as predictors and treatment targets of liver-related events and cardiovascular events in metabolic dysfunction-associated steatotic liver disease.

Nobuharu Tamaki Takefumi KimuraShun-Ichi WakabayashiTakeji UmemuraNamiki IzumiRohit LoombaMasayuki Kurosaki

Published in: Alimentary pharmacology & therapeutics (2024)

Cardiometabolic criteria can be used as predictors and treatment targets for cardiovascular event risk in MASLD. Developing predictors and therapeutic targets for liver-related events is a future challenge.

Keyphrases

cardiovascular events
coronary artery disease
oxidative stress
current status
replacement therapy
smoking cessation